Mobile Heartbeat announced it will be demonstrating its MH-CURE communication and workflow smartphone application at the 2015 Healthcare Information and Management Systems Society (HIMSS) annual conference, April 13-15, 2015, in Chicago.
The physician-patient relationship still plays a primary role in the overall patient experience despite increasing use of technology, according to a survey conducted by Nuance Communications Inc. The 3,000-person survey — conducted in the United States, United Kingdom and Germany — found that 97 percent of people agreed with this sentiment.
A new KLAS report on business intelligence (BI) found that healthcare organizations are looking for BI vendors with industry expertise and content to handle the growing complexities of data management. The report — entitled Health Analytics 2015: Moving toward the Continuum of Care — stresses that in-organization data is only a part of the picture and that data aggregation capabilities are more important than ever before.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
NavisHealth Solutions Inc. announced the general availability of its mobile patient engagement platform, Engage.
The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to treat certain patients who have previously had a tissue aortic valve replacement and are in need of a second one. This is the first transcatheter heart valve approved in the United States for valve-in-valve procedures in both high and extreme risk patients who have limited options or may otherwise go untreated.
The Medicines Company announced that the European Commission has granted marketing authorization for two acute care products – Kengrexal (cangrelor) and Raplixa (sealant powder). These approvals follow the issuance of positive opinions in January by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
A team of investigators at Children’s Hospital Los Angeles and the University of Southern California have developed the first fully implantable micropacemaker designed for use in a fetus with complete heart block. The team has done preclinical testing and optimization as reported in a recent issue of the journal Heart Rhythm.
AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow ticagrelor (Brilinta) 90 mg tablets whole. Unlike other P2Y12 inhibitors, ticagrelor has FDA approval to be crushed and administered in water by swallowing or via nasogastric tube.
Green Circle Health (GCH) announced the availability of its GCH Platform, an online patient-to-provider communications gateway. The platform enables the real-time exchange of patient vitals and health records among physicians, patients, family members and insurers. It leverages a patent-pending workflow to facilitate the collaborative sharing of data and enhance healthcare providers’ ability to proactively monitor, diagnose and treat medical conditions.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Aplio Platnium Series CV (cardiovascular) ultrasound systems from Toshiba America Medical Systems offer a comprehensive suite of dedicated technology for cardiac diagnosis. The series, including the Aplio 500 Platinum CV and Aplio 300 Platinum CV, feature 2-D Wall Motion Tracking, spectral and color Doppler, and Toshiba’s latest suite of guidance and workflow technologies.
Toshiba’s Aquilion One Vision Edition computed tomography (CT) system is capable of aiding clinicians in diagnosing patients presenting with chest pain. The system was showcased at the American College of Cardiology (ACC) annual meeting in San Diego, March 14-16.
Adding two non-invasive imaging tests to traditional cardiovascular disease risk factor assessment more precisely predicts a healthy patient’s future risk of heart attack, stroke, or premature death, according to a new study. The study was led by Icahn School of Medicine at Mount Sinai and published in the March 24 edition of the Journal of the American College of Cardiology (JACC).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
American College of Cardiology (ACC) President Kim Allan Williams Sr., M.D., FACC, issued the following statement in response to the Senate Health, Education, Labor and Pensions Committee on “America’s Health IT Transformation: Translating the Promise of Electronic Health Records into Better Care":
AliveCor Inc. announced the launch of a cloud-based electrocardiogram (ECG) analytics program with Preventice Solutions. Using AliveCor’s proprietary algorithms in this pilot program, Preventice Solutions intends to improve its internal workflow by reading the most critical ECGs first.
Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug, according to a new study. Catheter ablation was most successful in procedures where ablation was required in other areas in addition to the pulmonary vein. The study was presented at the American College of Cardiology’s 64th Annual Scientific Session.
March 31, 2015
